What is the recommended dosage of fluconazole (an antifungal medication) for treating a yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole Dosing for Yeast Infection

For uncomplicated vulvovaginal candidiasis, take a single 150 mg oral dose of fluconazole. 1, 2, 3

Uncomplicated Vulvovaginal Candidiasis

  • A single 150 mg oral dose is the standard treatment and achieves clinical cure rates exceeding 80-90% 1, 2, 3
  • This recommendation comes from the Infectious Diseases Society of America guidelines and is supported by the FDA-approved dosing 1, 3
  • Clinical response is typically evident within 5-16 days, with 97% of patients cured or markedly improved 4
  • No loading dose or multiple-day regimen is needed for straightforward cases 3

Complicated Vulvovaginal Candidiasis

For severe acute vulvovaginal candidiasis, use fluconazole 150 mg every 72 hours for 2-3 total doses. 1, 2, 5

  • Complicated cases include severe symptoms, recurrent infections (≥4 episodes per year), non-albicans Candida species, or immunocompromised hosts 1
  • The two-dose regimen achieves significantly higher clinical cure rates in severe vaginitis compared to single-dose therapy (P = 0.015) 5
  • Alternative approach: 10-14 days of topical therapy or oral fluconazole can be used for complicated cases 1, 2

Recurrent Vulvovaginal Candidiasis

For recurrent infections, use 10-14 days of induction therapy followed by fluconazole 150 mg once weekly for 6 months. 1, 2

  • This maintenance regimen prevents relapse in women with recurrent disease 1
  • The weekly dosing continues after initial control of the acute episode 1, 2

Urinary Tract Candida Infections (Different from Vaginal)

If the yeast infection involves the urinary tract rather than vaginal:

  • Symptomatic cystitis: Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1, 2
  • Pyelonephritis: Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1, 2

Key Clinical Considerations

  • Confirm diagnosis before treatment with wet mount preparation using saline and 10% KOH to demonstrate yeast or hyphae 1
  • Vaginal pH should be <4.5 in vulvovaginal candidiasis 1
  • If wet mount is negative but clinical suspicion remains high, obtain vaginal cultures for Candida 1
  • Over 90% of vaginal isolates are Candida albicans; non-albicans species predict significantly reduced response regardless of therapy duration 1, 5
  • Fluconazole is not recommended during pregnancy or lactation 6
  • Side effects are minimal, primarily mild gastrointestinal complaints (diarrhea and nausea in 1.9% each) 7

Common Pitfalls to Avoid

  • Do not use prolonged therapy for uncomplicated cases—single-dose is equally effective and improves compliance 1, 4
  • Do not assume treatment failure at 3-5 days; clinical response may take up to 14 days 4
  • Do not overlook the possibility of non-albicans species in treatment failures, which require culture confirmation 5
  • Relapse rates of 23% occur even with successful initial treatment, so counsel patients about recurrence 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluconazole Treatment for Yeast Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Research

Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.